Are neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as effective as Fournier's gangrene severity index for predicting the number of debridements in Fourner's gangrene?;Fournier gangreninde debridman sayi{dotless}si{dotless}ni{dotless} öngörmede nötrofil lenfosit orani{dotless} ve trombosit lenfosit orani{dotless} Fournier gangreni şiddet indeksi kadar etkili midir?

Ulusal Travma ve Acil Cerrahi Dergisi

Volumn 20, Issue 2, 2014, Pages 107-112

  Kahramanca, Şahin ^a   Kaya, Oskay ^b   Özgehan, Gülay ^b   Irem, Burak ^b   Dural, Ibrahim ^b   Küçükpinar, Tevfik ^b   Kargici, Hülagü ^b  

^a Kars State Hospital   (Turkey)

^b DISKAPI YILDIRIM BEYAZIT TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Fournier's gangrene; Neutrophil lymphocyte ratio; Platelet lymphocyte ratio; Prognostic factor

Indexed keywords

ANTIBIOTIC AGENT; IMMUNOSUPPRESSIVE AGENT; INFUSION FLUID;

ADULT; ARTICLE; BLOOD CELL COUNT; COST OF ILLNESS; DEBRIDEMENT; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; FOURNIER GANGRENE; FOURNIER S GANGRENE SEVERITY INDEX; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEUTROPHIL LYMPHOCYTE RATIO; OUTCOME ASSESSMENT; PLATELET LYMPHOCYTE RATIO; PREDICTIVE VALUE; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; STOMA; AGED; EMERGENCY HEALTH SERVICE; EVALUATION STUDY; GANGRENE; LENGTH OF STAY; LYMPHOCYTE; NEUTROPHIL; PATHOLOGY; PHYSIOLOGY; RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; UTILIZATION;

ADULT; AGED; DEBRIDEMENT; EMERGENCY SERVICE, HOSPITAL; FEMALE; FOURNIER GANGRENE; GANGRENE; HUMANS; LENGTH OF STAY; LYMPHOCYTES; MALE; MIDDLE AGED; NEUTROPHILS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84895863400     PISSN: 1306696X     EISSN: None     Source Type: Journal    
DOI: 10.5505/tjtes.2014.62829     Document Type: Article

References (23)

1. Morpurgo E, Galandiuk S. Fournier's gangrene. Surg Clin North Am 2002;82:1213-24.
2. Thwaini A, Khan A, Malik A, Cherian J, Barua J, Shergill I, Mammen K. Fournier's gangrene and its emergency management. Postgrad Med J 2006;82:516-9.
3. Eke N. Fournier's gangrene: a review of 1726 cases. Br J Surg 2000;87:718-28.
4. Mallikarjuna MN, Vijayakumar A, Patil VS, Shivswamy BS. Fournier's Gangrene: Current Practices. ISRN Surg 2012;2012:942437.
5. Sorensen MD, Krieger JN, Rivara FP, Klein MB, Wessells H. Fournier's gangrene: management and mortality predictors in a population based study. J Urol 2009;182:2742-7.
6. Liang SG, Chen HH, Lin SE, Chang CL, Lu CC, Hu WH. Fournier's gangrene in female patients. J Soc Colon Rectal Surgeon (Taiwan) 2008;19:57-61.
7. Nakatani H, Hamada S, Okanoue T, Kawamura A, Chikai T, Yamamoto S, et al. Fournier's gangrene in elderly patient: report of a case. J Med Invest 2011;58:255-8.
8. Ekingen G, Isken T, Agir H, Oncel S, Günlemez A. Fournier's gangrene in childhood: a report of 3 infant patients. J Pediatr Surg 2008;43:e39-42.
9. Wong CH, Khin LW, Heng KS, Tan KC, Low CO. The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections. Crit Care Med 2004;32:1535-41.
10. Laor E, Palmer LS, Tolia BM, Reid RE, Winter HI. Outcome prediction in patients with Fournier's gangrene. J Urol 1995;154:89-92.
11. Yilmazlar T, Ozturk E, Alsoy A, Ozguc H. Necrotizing soft tissue infections: APACHE II score, dissemination, and survival. World J Surg 2007;31:1858-62.
12. Yeniyol CO, Suelozgen T, Arslan M, Ayder AR. Fournier's gangrene: experience with 25 patients and use of Fournier's gangrene severity index score. Urology 2004;64:218-22.
13. J. Gutiérrez-Ochoa, HH. Castillo-de Lira, RF. Velázquez-Macías, M. Landa-Soler, MA. Robles-Scott. Utilidad del índice de gravedad en la Gangrena de Fournier. Estudio comparativo Usefulness of Fournier's gangrene severity index: a comparative study. Rev Mex Urol 2010;70: 27-30
14. Canbaz H, Caǧlikülekçi M, Altun U, Dirlik M, Türkmenoǧlu O, Taşdelen B, et al. Fournier's gangrene: analysis of risk factors affecting the prognosis and cost of therapy in 18 cases. Ulus Travma Acil Cerrahi Derg 2010;16:71-6.
15. Altarac S, Katušin D, Crnica S, Papeš D, Rajković Z, Arslani N. Fournier's gangrene: etiology and outcome analysis of 41 patients. Urol Int 2012;88:289-93.
16. Göktaş C, Yi{dotless}ldi{dotless}ri{dotless}m M, Horuz R, Faydaci{dotless} G, Akça O, Cetinel CA. Factors affecting the number of debridements in Fournier's gangrene: our results in 36 cases. Ulus Travma Acil Cerrahi Derg 2012;18:43-8.
17. Zagli G, Cianchi G, Degl'innocenti S, Parodo J, Bonetti L, Prosperi P, et al. Treatment of Fournier's Gangrene with Combination of Vacuum-Assisted Closure Therapy, Hyperbaric Oxygen Therapy, and Protective Colostomy. Case Rep Anesthesiol 2011;2011:430983.
18. Akcan A, Sözüer E, Akyildiz H, Yilmaz N, Küçük C, Ok E. Necessity of preventive colostomy for Fournier's gangrene of the anorectal region. Ulus Travma Acil Cerrahi Derg 2009;15:342-6.
19. Unalp HR, Kamer E, Derici H, Atahan K, Balci U, Demirdoven C, et al. Fournier's gangrene: evaluation of 68 patients and analysis of prognostic variables. J Postgrad Med 2008;54:102-5.
20. Sallami S, Maalla R, Gammoudi A, Ben Jdidia G, Tarhouni L, Horchani A. Fournier's gangrene: what are the prognostic factors? Our experience with 40 patients. Tunis Med 2012 Oct;90(10):708-14.
21. Azab B, Shah N, Akerman M, McGinn JT Jr. Value of platelet/lymphocyte ratio as a predictor of all-cause mortality after non-ST-elevation myocardial infarction. J Thromb Thrombolysis 2012;34:326-34.
22. Turkmen K, Erdur FM, Ozcicek F, Ozcicek A, Akbas EM, Ozbicer A, et al. Platelet-to-lymphocyte ratio better predicts inflammation than neutrophil-to-lymphocyte ratio in end-stage renal disease patients. Hemodial Int 2013;17:391-6.
23. Ishizuka M, Shimizu T, Kubota K. Neutrophil-to-Lymphocyte Ratio Has a Close Association With Gangrenous Appendicitis in Patients Undergoing Appendectomy. Int Surg 2012;97:299-304.